Cargando…
Prognostic value of Siglec-15 expression in patients with solid tumors: A meta-analysis
BACKGROUND: Siglec-15 is expressed in a variety of cancers. However, the role of Siglec-15 in the prognosis of cancer patients remains controversial. Therefore, we conducted a meta-analysis to clarify the potential prognostic value of Siglec-15 in solid tumors. METHODS: The PubMed, Web of Science, E...
Autores principales: | Jiang, Kui-Ying, Qi, Li-Li, Liu, Xin-Bo, Wang, Yong, Wang, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875589/ https://www.ncbi.nlm.nih.gov/pubmed/36713548 http://dx.doi.org/10.3389/fonc.2022.1073932 |
Ejemplares similares
-
Siglec-15 Promotes Tumor Progression in Osteosarcoma via DUSP1/MAPK Pathway
por: Fan, Meng-ke, et al.
Publicado: (2021) -
The intriguing roles of Siglec family members in the tumor microenvironment
por: Jiang, Kui-Ying, et al.
Publicado: (2022) -
Prognostic Value of CD9 in Solid Tumor: A Systematic Review and Meta-Analysis
por: Zeng, Ping, et al.
Publicado: (2021) -
Prognostic value of PD-L1 and Siglec-15 expression in patients with nasopharyngeal carcinoma
por: Zhao, Ju, et al.
Publicado: (2022) -
Prognostic Values of TIM-3 Expression in Patients With Solid Tumors: A Meta-Analysis and Database Evaluation
por: Qin, Shuang, et al.
Publicado: (2020)